25th International Congress on Pharmaceutical Biotechnology
University of Medicine and Pharmacy Victor Babeș Timișoara, Romania
Title: TTYH2- Promising colon cancer treatment development
Biography: Felicia Andrei
Most of the cancers harbor molecular alterations in their genomes. These mutations have not yet been comprehensively explored in the colon cancer. TTYH2, a human homologue of the Drosophila melanogaster gene tweety, is involved in cell proliferation and cell aggregation.The TTYH2 gene may play an important role in regulating both proliferating and metastatic potentials of colorectal cancer. Here we present in the first part a large scale database sequencing study of colon cancer, frecquent in Romania but also in the world. The aim was to demonstrate its power to produce somatic expresions.The tissue specificity of these gene is expressed at higher level in brain and testis and at lower levels in heart, ovary, spleen and peripheral blood leukocytes as well as in the skin. Up-regulated in 13 of 16 renal carcinoma and in 164 total unique samples of colon carcinoma, surgical specimens examined, our results reveal the genetic basis of 180 cases. So we identified and deeply characterized this driver of neocellular changes. These findings broaden our understanding of colon cancers and lead to new diagnostic and therapeutic approaches using TTYH2 antibodies.